These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11498723)

  • 1. Opposite effects of nefazodone in two human models of anxiety.
    Silva M; Hetem LA; Guimarães FS; Graeff FG
    Psychopharmacology (Berl); 2001 Aug; 156(4):454-60. PubMed ID: 11498723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do panic patients process unconditioned fear vs. conditioned anxiety differently than normal subjects?
    Del-Ben CM; Vilela JA; Hetem LA; Guimarães FS; Graeff FG; Zuardi AW
    Psychiatry Res; 2001 Nov; 104(3):227-37. PubMed ID: 11728612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between two models of experimental anxiety in healthy volunteers and panic disorder patients.
    Graeff FG; Silva M; Del Ben CM; Zuardi AW; Hetem LA; Guimarães FS
    Neurosci Biobehav Rev; 2001 Dec; 25(7-8):753-9. PubMed ID: 11801299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buspirone decreases physiological reactivity to unconditioned and conditioned aversive stimuli.
    Bond AJ; Wingrove J; Baylis M; Dalton J
    Psychopharmacology (Berl); 2003 Jan; 165(3):291-5. PubMed ID: 12420156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity.
    Sargent P; Williamson DJ; Pearson G; Odontiadis J; Cowen PJ
    Psychopharmacology (Berl); 1997 Aug; 132(3):296-302. PubMed ID: 9292630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of d-fenfluramine on human experimental anxiety.
    Hetem LA; de Souza CJ; Guimarães ES; Zuardi AW; Graeff FG
    Psychopharmacology (Berl); 1996 Oct; 127(3):276-82. PubMed ID: 8912406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation.
    Garcia-Leal C; Del-Ben CM; Leal FM; Graeff FG; Guimarães FS
    J Psychopharmacol; 2010 May; 24(5):683-94. PubMed ID: 19251828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of antidepressants: focus on nefazodone.
    DeVane CL; Grothe DR; Smith SL
    J Clin Psychiatry; 2002; 63 Suppl 1():10-7. PubMed ID: 11890560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate].
    Muraki I
    Hokkaido Igaku Zasshi; 2001 Mar; 76(2):57-70. PubMed ID: 11344903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotonin.
    Narayan M; Anderson G; Cellar J; Mallison RT; Price LH; Nelson JC
    J Clin Psychopharmacol; 1998 Feb; 18(1):67-71. PubMed ID: 9472845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.
    Sharpley AL; Williamson DJ; Attenburrow ME; Pearson G; Sargent P; Cowen PJ
    Psychopharmacology (Berl); 1996 Jul; 126(1):50-4. PubMed ID: 8853216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 5-HT in stress, anxiety, and depression.
    Graeff FG; Guimarães FS; De Andrade TG; Deakin JF
    Pharmacol Biochem Behav; 1996 May; 54(1):129-41. PubMed ID: 8728550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist.
    Burghardt NS; Bush DE; McEwen BS; LeDoux JE
    Biol Psychiatry; 2007 Nov; 62(10):1111-8. PubMed ID: 17524369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone.
    Waldinger MD; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 2001 Jun; 21(3):293-7. PubMed ID: 11386492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective and neurovegetative changes in healthy volunteers and panic patients performing simulated public speaking.
    Parente AC; Garcia-Leal C; Del-Ben CM; Guimarães FS; Graeff FG
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):663-71. PubMed ID: 15961294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing.
    Inoue T; Hashimoto S; Tsuchiya K; Izumi T; Ohmori T; Koyama T
    Eur J Pharmacol; 1996 Sep; 311(1):1-6. PubMed ID: 8884229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of metergoline on human anxiety.
    Graeff FG; Zuardi AW; Giglio JS; Lima Filho EC; Karniol IG
    Psychopharmacology (Berl); 1985; 86(3):334-8. PubMed ID: 3929304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone.
    Pullar IA; Carney SL; Colvin EM; Lucaites VL; Nelson DL; Wedley S
    Eur J Pharmacol; 2000 Oct; 407(1-2):39-46. PubMed ID: 11050288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anxiolytic effects of serotonin reuptake inhibitors and their mechanism of action].
    Hashimoto S
    Hokkaido Igaku Zasshi; 2000 Nov; 75(6):421-36. PubMed ID: 11193934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET.
    Meyer JH; Cho R; Kennedy S; Kapur S
    Psychopharmacology (Berl); 1999 Jun; 144(3):279-81. PubMed ID: 10435395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.